The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

LUNG FINANCIAL STATEMENTS

Pulmonx Corp — balance sheet, income statement and cash flow trends

LUNGPulmonx Corp

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M050 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue87.4 M $Gross Profit67.4 M $ · 77%Operating Income-46.3 M $ · -53%Pre-tax Income-47.5 M $ · -54%Net Income to Owners-48.1 M $ · -55%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue87.4 M $-3.4%
Gross Profit67.4 M $+1.8%
Operating Income-46.3 M $—
EBITDA-43.1 M $—
Net Income to Owners-48.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0100 M200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets114.7 M
  • Equity39.2 M $34%
  • Current Liabilities20.4 M $18%
  • Long-term Liabilities55.1 M $48%

Key Figures

YoY change
Total Assets114.7 M $-22.1%
Total Liabilities75.5 M $-3.3%
Total Equity39.2 M $-43.3%
Cash & ST Investments55.8 M $-33.7%
Total Debt56.2 M $-1.1%
Net Debt368 K $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-30 M-20 M-10 M0-30.6 M $Operating8.7 M $Investing1.7 M $Financing-20.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-30.6 M $—
Capital Expenditures112 K $-87.2%
Free Cash Flow-30.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LUNG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.